Immunotech Biopharm (6978.HK) Earnings Analysis
Immunotech Biopharm (6978.HK) next reports earnings on 2026-08-21. Trailing P/E -1.07.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6978.HK next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
6978.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-03-31 | -0.19515 HKD | n/a | n/a | n/a |
| 2024-08-23 | -0.19307 HKD | n/a | n/a | n/a |
6978.HK valuation and analyst view
| Trailing P/E | -1.07 |
|---|---|
| Trailing EPS | -0.38175 HKD |
| Price / book | -19.35 |
| Dividend yield | 0.00% |
| Market cap | 0.28B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Immunotech Biopharm (6978.HK)'s next earnings date?
Immunotech Biopharm is next scheduled to report on 2026-08-21.
Did 6978.HK beat earnings last quarter?
Consensus estimate data was not available for 6978.HK's 2025-03-31 report.
What is 6978.HK's current P/E ratio and EPS?
6978.HK trades at a trailing P/E of -1.07 on trailing EPS of -0.38175321781848237 HKD.
What do analysts rate 6978.HK?
6978.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.